Pontocerebellar Hypoplasia Type 2A

Objective of the Paper: Show the importance of genetic diagnosis in children with movement disorders.

Key points. Pontocerebellar hypoplasia (PCH) is a heterogeneous group of autosomal recessive neurodegenerative diseases. They are characterized by a beginning in the prenatal period, a slowdown in the growth of the cerebellum, frontal and occipital cortex of the cerebral hemispheres, and microcephaly. The disease manifests itself from birth and is steadily progressing. PCH2A is the most part of the described variant of the disease. It is characterized by moderate respiratory disorders, swallowing disorders, dyskinesia at rest, choreic hyperkinesias, muscle spasticity, pharmacoresistant epilepsy and progressive microcephaly. To date, about 80–100 cases have been described. An own observation of a patient with pontocerebellar hypoplasia of type 2A is presented. The girl noted a slowly progressive violation of motor, speech and mental development of a severe degree of severity, epileptic seizures and extrapyramidal paroxysms.

Conclusion. Timely genetic diagnosis in children with the phenotype of microcephaly and cerebral palsy allows reaching an etiological diagnosis, determining treatment tactics, rehabilitation prognosis and helps in the future to plan the birth of healthy children in the family.

1. Bierhals T., Korenke G.C., Uyanik G., Kutsche K. Pontocerebellar hypoplasia type 2 and TSEN2: review of the literature and two novel mutations. Eur. J. Med. Genet. 2013; 56(6): 325–30. DOI: 10.1016/j.ejmg.2013.03.009

2. Brun R. Zur Kenntnis der Bildungsfehler des Kleinhirns. Epikritische Bemerkungen zur Entwicklungspathologie, Morphologie und Klinik der umschriebenen Entwicklungshemmungen des Neozerebellums. Schweiz Arch. Neurol. Psychiatr. 1917; 1: 48–105.

3. Koster S. Two cases of hypoplasia ponto-neocerebellaris. Acta Psychiatr. (Københ). 1926; 1: 47–76.

4. Dijk T., Baas F., Barth P.G., Poll-The B.T. What’s new in pontocerebellar hypoplasia? An update on genes and subtypes. Orphanet J. Rare Dis. 2018; 13(1): 92. DOI: 10.1186/s13023-018-0826-2

5. Pacheva I.H., Todorov T., Ivanov I., Tartova D. et al. TSEN54 Gene related pontocerebellar hypoplasia type 2 could mimic dyskinetic cerebral palsy with severe psychomotor retardation. Front. Pediatr. 2018; 6: 1. DOI: 10.3389/fped.2018.00001

6. Coolen M., Altin N., Rajamani K., Pereira E. et al. Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation. Am. J. Hum. Genet. 2022; 109(5): 909–27. DOI: 10.1016/j.ajhg.2022.03.010

7. Steinlin M., Klein A., Haas-Lude K., Zafeiriou D. et al. Pontocerebellar hypoplasia type 2: variability in clinical and imaging findings. Eur. J. Paediatr. Neurol. 2007; 11(3): 146–52. DOI: 10.1016/j.ejpn.2006.11.012

8. Sekulovski S., Devant P., Panizza S. et al. Assembly defects of human tRNA splicing endonuclease contribute to impaired pre tRNA processing in pontocerebellar hypoplasia. Trowitzsch S. Nat. Commun. 2021;12(1):5610. doi: 10.1038/s41467-021-25870-3.

9. Cassandrini D., Biancheri R., Tessa A., Di Rocco M. et al. Pontocerebellar hypoplasia: clinical, pathologic, and genetic studies. Neurology. 2010; 75(16): 1459–64. DOI: 10.1212/WNL.0b013e3181f88173

10. Laugwitz L., Buchert R., Groeschel S., Riess A. et al. Pontocerebellar hypoplasia type 11: Does the genetic defect determine timing of cerebellar pathology? Eur. J. Med. Genet. 2020; 63(7): 103938. DOI: 10.1016/j.ejmg.2020.103938

11. Sánchez-Albisua I., Frölich S., Barth G.P., Steinlin M. et al. Natural course of pontocerebellar hypoplasia type 2A. Orphanet J. Rare Dis. 2014; 9: 70. DOI: 10.1186/1750-1172-9-70

12. Battini R., D’Arrigo S., Cassandrini D., Guzzetta A. et al. Novel mutations in TSEN54 in pontocerebellar hypoplasia type 2. J. Child Neurol. 2014; 29(4): 520–5. DOI: 10.1177/0883073812470002

13. Rudaks I.L., Moore L., Shand K.L., Wilkinson C. et al. Novel TSEN54 mutation causing pontocerebellar hypoplasia type 4. Pediat. Neurol. 2011; 45(3): 185–8. DOI:10.1016/j.pediatrneurol.2011.05.009

14. Ermakova O., Orsini T., Fruscoloni P., Chiani F. et al. Three dimensional X-ray imaging of β-galactosidase reporter activity by micro-CT: implication for quantitative analysis of gene expression. Brain Sci. 2021; 11(6): 746. DOI: 10.3390/ brainsci11060746

15. Accogli A., Addour-Boudrahem N., Srour M. Diagnostic approach to cerebellar hypoplasia. Cerebellum. 2021; 20(4): 631–58. DOI: 10.1007/s12311-020-01224-5

16. Dadali E.L., Akimova I.A., Semenova N.A., Guseva D.M. et al. Clinical and genetic characteristics of ponto-cerebellar hypoplasia caused by mutations in the TSEN54 gene (OMIM: 277470). Neuromuscular Diseases. 2019; 9(2): 30–6. (in Russian). DOI: 10.17650/2222-8721-2019-9-2-30-36

17. Sokolov P.L., Chebanenko N.V., Zykov V.P., Kanivets I.V. et al. Congenital cerebral palsy: genetic cause and nosological integrity. Russian Journal of Child Neurology. 2020; 15(3–4): 65–77. (in Russian). DOI: 10.17650/2073-8803-2020-15-3-4-65-77

18. Prityko A.G., Chebanenko N.V., Sokolov P.L., Zykov V.P. et al. Genetic aspects of pathogenesis of congenital spastic cerebral paralysis. Acta Biomedica Scientifica. 2019; 4(3): 28–39. (in Russian). DOI: 10.29413/ABS.2019-4.3.4

19. Greenbaum L., Maya I., Sagi-Dain L., Sukenik-Halevy R. et al. Chromosomal microarray analysis in pregnancies with corpus callosum or posterior fossa anomalies. Neurol. Genet. 2021; 7(3): e585. DOI: 10.1212/NXG.0000000000000585

20. Xia M., Yang X., Fu J., Teng Z. et al. Application of chromosome microarray analysis in prenatal diagnosis. BMC Pregnancy Childbirth. 2020; 20(1): 696. DOI: 10.1186/s12884-020-03368-y

21. Zou Z., Huang L., Lin S., He Z. et al. Prenatal diagnosis of posterior fossa anomalies: additional value of chromosomal microarray analysis in fetuses with cerebellar hypoplasia. Prenat. Diagn. 2018; 38(2): 91–8. DOI: 10.1002/pd.5190

22. Mastromoro G., Guadagnolo D., Khaleghi Hashemian N., Marchionni E. et al. Molecular approaches in fetal malformations, dynamic anomalies and soft markers: diagnostic rates and challenges systematic review of the literature and meta-analysis. Diagnostics (Basel). 2022; 12(3): 575. DOI: 10.3390/diagnostics12030575